Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS

AIDS

Volumn 9, Issue 5, 1995, Pages 471-477

  Cooper, D ^a   McCluskey, P ^a   Mathieson, L ^a   Borme, K K ^a   Skinhoj, P ^a   Prause, J U ^a   Tinning, S ^a   Barton, S ^a   Johnson, M ^a   Main, J ^a   Pinching, A ^a   Migdal, C ^a   Mitchell, S ^a   Katlama, C ^a   Hoang, P L ^a   Matheron, S ^a   Cochereau, I ^a   Rozenbaum, W ^a   Zazoun, L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

AIDS; Cytomegalovirus retinitis; Oral gangiclovir

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; ASTHENIA; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EUROPE; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; OPHTHALMOSCOPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT INFECTION; RETINITIS; SEPSIS; THROMBOCYTOPENIA;

EID: 0028959729     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199505000-00009     Document Type: Article

References (0)